MYD88 and fatty liver disease: As per a recent report by Yang et al., in this study hepatocytes in CDAA-fed mice developed steatosis via the TLR4/TRIF pathway and independently of the TLR4/Myd88 pathway, strongly supporting the LPS-mediated potentiation of hepatic steatosis in the same model [24].